
TY  - JOUR
A1  - Butale, Bakani 
A1  - Woolley, Ian 
A1  - Cisera, Kathryn 
A1  - Korman, Tony 
A1  - Soldatos, Georgia 
T1  - <i>Corrigendum to</i>: Under-utilisation of cardioprotective glucose-lowering medication in diabetics living with HIV
JF  - Sexual Health
JO  - Sex. Health
Y1  - 2022
VL  - 19
IS  - 6
SP  - 583
EP  - 583
KW  - 
UR  - https://doi.org/10.1071/SH22070_CO 
N2  - Diabetes is an increasingly common co-morbidity in people living with HIV (PLWH). Given new evidence demonstrating cardiovascular benefits of sodium glucose transporter 2 inhibitors (SGLT2i) and glucagon-like peptide 1 receptor agonists (GLP1RA) in diabetic patients, we reviewed medical charts of 262 PLWH at Monash Health through a 1-year retrospective cohort study to determine the rates of their use. Prevalence of diabetes was 13.4% (35) and 60% (21) had microvascular and macrovascular complications. Only 4% (95% CI 0.1%&#x2013;19.6%) of diabetic patients were receiving SGLT2i and 19% (95% CI 6%&#x2013;39.4%) were receiving GLP1RA. Prescribers should carefully consider their choice of glucose-lowering medication when treating PLWH. 
ER  -

